Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Oncolytics Biotech Inc. (T.ONC) had Income from Continuous Operations of -4.66M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-4.66M |
|
-- |
|
-- |
|
-- |
|
-4.91M |
|
-- |
|
-4.66M |
|
-4.66M |
|
-4.66M |
|
|
Income from Continuous Operations |
-4.66M |
-4.66M |
|
-4.66M |
|
-4.91M |
|
-4.84M |
|
84.63M |
|
84.63M |
|
-0.06 |
|
-0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.72M |
|
-- |
|
-- |
|
-- |
|
9.20M |
|
4.52M |
|
4.52M |
|
4.52M |
|
86.42M |
|
| Cash Flow Statement Financials | |
-4.53M |
|
-- |
|
4.10M |
|
11.10M |
|
10.66M |
|
-0.45M |
|
0.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
0.10 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-102.97% |
|
-102.97% |
|
-33.94% |
|
-92.82% |
|
0.08 |
|
-0.05 |
|
-0.05 |
|